Programmed death ligand 1 (PD-L1) expression, microsatellite instability-high/defective mismatch repair (MSI-H/dMMR), and tumor mutation burden (TMB) are common predictive biomarkers in clinical practice 3-5. The gene discussed is CD274; the disease is neoplasm.